Pharmacopeia
Master Compare
Compare candidate-facing canonical Pharmacopeia fields side by side. Isolated AI-draft proposals are never included.
| Field |
BENZYL PENICILLIN
Anti-infectives · Anti-infectives · Level 1
|
AMPICILLIN
Anti-infectives · Anti-infectives · Level 1
|
|---|---|---|
| Mechanism of action | β lactam antibiotic |
Contains a beta lactam ring structure. Betalactam antibiotics inhibit the growth of sensitive bacteria by inactivating transpeptidase enzymes located in the bacterial cell membrane, inhibiting crosslinkage of peptidoglycans and thus impairing cell wall synthesis |
| Absorption | Orally not absorbed (need penicillin V) |
BA 62% |
| Distribution | CSF and bone penetration if inflammation present |
penetration into CSF occurs with inflamed meninges only |
| Protein binding | 60% PB |
20% PB |
| Volume of distribution | Vd <1L/kg |
— |
| Metabolism | Inactive metabolite penicollic acid |
Some Hepatic Metabolism |
| Excretion | 90% excreted in urine by tubular secretion |
Mostly unchanged in urine. |
| Adverse Effects Toxicity | GIT– abdominal pain, N/V/D, pseudomembranous colitis, hepatitis |
— |
| Antimicrobial Spectrum | Narrow-Spectrum Highly bactericidal, only Targets Synergistic effects with |
Moderate spectrum |
| Class Group | ANTIBIOTIC: |
ANTIBIOTIC: |
| Introduction | Narrow spectrum naturally occurring penicillin |
Betalactam |
| Legacy Cicm Level | Level 1 |
Level 1 |
| Resistance Mechanism | Resistance |
Bacteria produce beta lactamases, which hydrolyse and inactivate the antibiotic Resistance |